First, we studied the effect of IFN-β alone and in combination with gemcitabine in three human pancreatic cancer cell lines: two IFN-β sensitive cell lines (BxPC-3 and CFPAC-1) and an IFN-β insensitive cell line (Panc-1) [16]. Here, IFNB1 is linked to pancreatic neoplasm.